Home/Pipeline/Posaconazole Delayed-Release Tablet

Posaconazole Delayed-Release Tablet

Antifungal (Infection)

ApprovedCommercial (US & China)

Key Facts

Indication
Antifungal (Infection)
Phase
Approved
Status
Commercial (US & China)
Company

About Sinotherapeutics

A Chinese pharma company developing complex generics and novel formulations with FDA/NMPA-approved products in oncology, immunology, and metabolic diseases.

View full company profile